oral PARP1-selective polymerase inhibitor

oral efficacy in BRCA1 mutant xenograft

from scaffold hopping from lit. PARP1/2 inh.

Bioorg. Med. Chem., Oct. 6, 2020

Lupin Ltd., Pune, IN

“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks